Hamill John P.
Aprea Therapeutics, Inc. · SrVP/CFO/Prin Fin & Acct Ofcr
Hamill John P. is listed in public filings as officer: SrVP/CFO/Prin Fin & Acct Ofcr. This Hamill John P. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Aprea Therapeutics, Inc. (APRE). Investors use Hamill John P.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $4.4k5.7k shares | BuyJan 30, 2026 | $0.765 | -- | |
| $5.1k5.7k shares | BuyJan 30, 2026 | $0.89 | -- | |
| $5.8k5k shares | BuyDec 10, 2025 | $1.17 | -- | |
| $5.2k5k shares | BuyDec 10, 2025 | $1.04 | -- | |
| $12350 shares | BuyOct 11, 2024 | $2.46 | -- | |
| $1.2k450 shares | BuyOct 10, 2024 | $2.61 | -- |